Actinium Pharmaceuticals, Inc. (ATNM)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 201.95M |
| Enterprise value | 127.39M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.26k |
| Price/book (mrq) | 5.55 |
| Enterprise value/revenue | 1.57k |
| Enterprise value/EBITDA | -2.49 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.08 |
| 52-week change 3 | -24.92% |
| S&P500 52-week change 3 | 22.36% |
| 52-week high 3 | 9.86 |
| 52-week low 3 | 4.00 |
| 50-day moving average 3 | 7.78 |
| 200-day moving average 3 | 6.23 |
Share statistics
| Avg vol (3-month) 3 | 362.54k |
| Avg vol (10-day) 3 | 275.93k |
| Shares outstanding 5 | 29.4M |
| Implied shares outstanding 6 | 31.64M |
| Float 8 | 28.61M |
| % held by insiders 1 | 2.16% |
| % held by institutions 1 | 24.44% |
| Shares short (15 Apr 2024) 4 | 1.98M |
| Short ratio (15 Apr 2024) 4 | 3.04 |
| Short % of float (15 Apr 2024) 4 | 6.73% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.73% |
| Shares short (prior month 15 Mar 2024) 4 | 1.82M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 11 Aug 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:30 |
| Last split date 3 | 11 Aug 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -12,769.14% |
Management effectiveness
| Return on assets (ttm) | -33.17% |
| Return on equity (ttm) | -94.92% |
Income statement
| Revenue (ttm) | 81k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -51.71M |
| Net income avi to common (ttm) | -48.82M |
| Diluted EPS (ttm) | -1.83 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 76.68M |
| Total cash per share (mrq) | 2.61 |
| Total debt (mrq) | 2.11M |
| Total debt/equity (mrq) | 5.81% |
| Current ratio (mrq) | 9.21 |
| Book value per share (mrq) | 1.32 |
Cash flow statement
| Operating cash flow (ttm) | -47.34M |
| Levered free cash flow (ttm) | -29.7M |
© 2024 Yahoo. All rights reserved.